A citation-based method for searching scientific literature

Oren Smaletz, Gustavo Ismael, Maria Del Pilar Estevez-Diz, Ivana L O Nascimento, Ana Luiza Gomes de Morais, Geraldo Felício Cunha-Junior, Sergio J Azevedo, Venancio A Alves, Ana Maria Moro, Fernanda P Yeda, Mariana Lopes Dos Santos, Indrani Majumder, Eric W Hoffman. Int J Gynecol Cancer 2021
Times Cited: 2







List of co-cited articles
4 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors.
A M Scott, D Geleick, M Rubira, K Clarke, E C Nice, F E Smyth, E Stockert, E C Richards, F J Carr, W J Harris,[...]. Cancer Res 2000
81
100


A phase II trial with anti-Lewis-Y monoclonal antibody (hu3S193) for the treatment of platinum resistant/refractory ovarian, fallopian tube and primary peritoneal carcinoma.
Oren Smaletz, Maria D P E Diz, Claudio C do Carmo, Jorge Sabbaga, Geraldo F Cunha-Junior, Sergio J Azevedo, Fernando C Maluf, Carlos H Barrios, Ronaldo L Costa, Ana G Fontana,[...]. Gynecol Oncol 2015
16
100

Specificity analysis of blood group Lewis-y (Le(y)) antibodies generatedagainst synthetic and natural Le(y) determinants.
K Kitamura, E Stockert, P Garin-Chesa, S Welt, K O Lloyd, K L Armour, T P Wallace, W J Harris, F J Carr, L J Old. Proc Natl Acad Sci U S A 1994
92
100

Interdomain spacing and spatial configuration drive the potency of IgG-[L]-scFv T cell bispecific antibodies.
Brian H Santich, Jeong A Park, Hoa Tran, Hong-Fen Guo, Morgan Huse, Nai-Kong V Cheung. Sci Transl Med 2020
16
50

Cytokines in the Treatment of Cancer.
Kevin C Conlon, Milos D Miljkovic, Thomas A Waldmann. J Interferon Cytokine Res 2019
85
50

Format and geometries matter: Structure-based design defines the functionality of bispecific antibodies.
Steffen Dickopf, Guy J Georges, Ulrich Brinkmann. Comput Struct Biotechnol J 2020
6
50

Production process reproducibility and product quality consistency of transient gene expression in HEK293 cells with anti-PD1 antibody as the model protein.
Kai Ding, Lei Han, Huifang Zong, Junsheng Chen, Baohong Zhang, Jianwei Zhu. Appl Microbiol Biotechnol 2017
14
50

Antibodies directed against Lewis-Y antigen inhibit signaling of Lewis-Y modified ErbB receptors.
Markus Klinger, Hesso Farhan, Herwig Just, Helmut Drobny, Gottfried Himmler, Hans Loibner, Geert C Mudde, Michael Freissmuth, Veronika Sexl. Cancer Res 2004
53
50

Enhancive effects of Lewis y antigen on CD44-mediated adhesion and spreading of human ovarian cancer cell line RMG-I.
Lili Gao, Limei Yan, Bei Lin, Jian Gao, Xiuyun Liang, Yanyan Wang, Juanjuan Liu, Shulan Zhang, Masao Iwamori. J Exp Clin Cancer Res 2011
34
50

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
50

Lewis y antigen promotes the proliferation of ovarian carcinoma-derived RMG-I cells through the PI3K/Akt signaling pathway.
Juanjuan Liu, Bei Lin, Yingying Hao, Yue Qi, Liancheng Zhu, Feifei Li, Dawo Liu, Jianping Cong, Shulan Zhang, Masao Iwamori. J Exp Clin Cancer Res 2009
38
50

Lewis(y) antigen stimulates the growth of ovarian cancer cells via regulation of the epidermal growth factor receptor pathway.
Juan-Juan Liu, Bei Lin, Ying-Ying Hao, Fei-Fei Li, Da-Wo Liu, Yue Qi, Lian-Cheng Zhu, Shu-Lan Zhang, Masao Iwamori. Oncol Rep 2010
51
50

Lewis(y) antigen (CD174) and apoptosis in gastric and colorectal carcinomas: correlations with clinical and prognostic parameters.
S E Baldus, S P Mönig, T K Zirbes, J Thakran, D Köthe, M Köppel, F-G Hanisch, J Thiele, P M Schneider, A H Hölscher,[...]. Histol Histopathol 2006
16
50

Adoptive transfer of T cells modified with a humanized chimeric receptor gene inhibits growth of Lewis-Y-expressing tumors in mice.
Jennifer A Westwood, Mark J Smyth, Michele W L Teng, Maria Moeller, Joseph A Trapani, Andrew M Scott, Fiona E Smyth, Glenn A Cartwright, Barbara E Power, Dirk Hönemann,[...]. Proc Natl Acad Sci U S A 2005
107
50




Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma.
Avery D Posey, Robert D Schwab, Alina C Boesteanu, Catharina Steentoft, Ulla Mandel, Boris Engels, Jennifer D Stone, Thomas D Madsen, Karin Schreiber, Kathleen M Haines,[...]. Immunity 2016
262
50

Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group-related antigens.
S Zhang, H S Zhang, C Cordon-Cardo, V E Reuter, A K Singhal, K O Lloyd, P O Livingston. Int J Cancer 1997
181
50

Expression of CD147 and Lewis y antigen in ovarian cancer and their relationship to drug resistance.
Jian Gao, Zhenhua Hu, Juanjuan Liu, Dawo Liu, Yanyan Wang, Mingbo Cai, Danye Zhang, Mingzi Tan, Bei Lin. Med Oncol 2014
18
50

Expression and correlation of Lewis y antigen and integrins α5 and β1 in ovarian serous and mucinous carcinoma.
Quanrong Li, Shuice Liu, Bei Lin, Limei Yan, Yifei Wang, Changzhi Wang, Shulan Zhang. Int J Gynecol Cancer 2010
19
50


Elevated levels of Lewis y and integrin α5β1 correlate with chemotherapeutic drug resistance in epithelial ovarian carcinoma.
Zhenhua Hu, Song Gao, Jian Gao, Rui Hou, Chuan Liu, Juanjuan Liu, Beibei Li, Dawo Liu, Shulan Zhang, Bei Lin. Int J Mol Sci 2012
23
50

Expression of Lewis y antigen and integrin αv, β3 in ovarian cancer and their relationship with chemotherapeutic drug resistance.
Jian Gao, Zhenhua Hu, Dawo Liu, Juanjuan Liu, Chuan Liu, Rui Hou, Song Gao, Danye Zhang, Shulan Zhang, Bei Lin. J Exp Clin Cancer Res 2013
16
50

Mode of cytotoxic action of T cell-engaging BiTE antibody MT110.
Cornelia Haas, Eva Krinner, Klaus Brischwein, Patrick Hoffmann, Ralf Lutterbüse, Bernd Schlereth, Peter Kufer, Patrick A Baeuerle. Immunobiology 2009
125
50

Humanization of the murine anti-human CD3 monoclonal antibody OKT3.
J R Adair, D S Athwal, M W Bodmer, S M Bright, A M Collins, V L Pulito, P E Rao, R Reedman, A L Rothermel, D Xu. Hum Antibodies Hybridomas 1994
34
50

T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand.
Kaushik Choudhuri, David Wiseman, Marion H Brown, Keith Gould, P Anton van der Merwe. Nature 2005
225
50

Highly tumor-reactive, internalizing, mouse monoclonal antibodies to Le(y)-related cell surface antigens.
I Hellström, H J Garrigues, U Garrigues, K E Hellström. Cancer Res 1990
220
50

Lewis Y antigen modified CD47 is an independent risk factor for poor prognosis and promotes early ovarian cancer metastasis.
Mingzi Tan, Liancheng Zhu, Huiyu Zhuang, Yingying Hao, Song Gao, Shuice Liu, Qing Liu, Dawo Liu, Juanjuan Liu, Bei Lin. Am J Cancer Res 2015
14
50


High expression of Lewis y/b antigens is associated with decreased survival in lymph node negative breast carcinomas.
Zahra Madjd, Tina Parsons, Nicholas F S Watson, Ian Spendlove, Ian Ellis, Lindy G Durrant. Breast Cancer Res 2005
64
50

Overcoming resistance to HER2-targeted therapy with a novel HER2/CD3 bispecific antibody.
Andres Lopez-Albaitero, Hong Xu, Hongfen Guo, Linlin Wang, Zhihao Wu, Hoa Tran, Sarat Chandarlapaty, Maurizio Scaltriti, Yelena Janjigian, Elisa de Stanchina,[...]. Oncoimmunology 2017
38
50

A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors.
Marina Bacac, Tanja Fauti, Johannes Sam, Sara Colombetti, Tina Weinzierl, Djamila Ouaret, Walter Bodmer, Steffi Lehmann, Thomas Hofer, Ralf J Hosse,[...]. Clin Cancer Res 2016
144
50

Cytokines as potential combination agents with PD-1/PD-L1 blockade for cancer treatment.
Ghasem Rahimi Kalateh Shah Mohammad, Atefeh Ghahremanloo, Arash Soltani, Esmat Fathi, Seyed Isaac Hashemy. J Cell Physiol 2020
8
50

Retargeting T cells to GD2 pentasaccharide on human tumors using Bispecific humanized antibody.
Hong Xu, Ming Cheng, Hongfen Guo, Yuedan Chen, Morgan Huse, Nai-Kong V Cheung. Cancer Immunol Res 2015
43
50


Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial.
Ruth Ladenstein, Ulrike Pötschger, Dominique Valteau-Couanet, Roberto Luksch, Victoria Castel, Isaac Yaniv, Genevieve Laureys, Penelope Brock, Jean Marie Michon, Cormac Owens,[...]. Lancet Oncol 2018
102
50

Anti-CD20/CD3 T cell-dependent bispecific antibody for the treatment of B cell malignancies.
Liping L Sun, Diego Ellerman, Mary Mathieu, Maria Hristopoulos, Xiaocheng Chen, Yijin Li, Xiaojie Yan, Robyn Clark, Arthur Reyes, Eric Stefanich,[...]. Sci Transl Med 2015
88
50


Characterization of the first-in-class T-cell-engaging bispecific single-chain antibody for targeted immunotherapy of solid tumors expressing the oncofetal protein claudin 6.
Christiane R Stadler, Hayat Bähr-Mahmud, Laura M Plum, Kathrin Schmoldt, Anne C Kölsch, Özlem Türeci, Ugur Sahin. Oncoimmunology 2015
22
50

MGD011, A CD19 x CD3 Dual-Affinity Retargeting Bi-specific Molecule Incorporating Extended Circulating Half-life for the Treatment of B-Cell Malignancies.
Liqin Liu, Chia-Ying K Lam, Vatana Long, Lusiana Widjaja, Yinhua Yang, Hua Li, Linda Jin, Steve Burke, Sergey Gorlatov, Jennifer Brown,[...]. Clin Cancer Res 2017
39
50

Bispecific antibodies: a mechanistic review of the pipeline.
Aran F Labrijn, Maarten L Janmaat, Janice M Reichert, Paul W H I Parren. Nat Rev Drug Discov 2019
260
50

Identification and characterization of fully human anti-CD22 monoclonal antibodies.
Xiaodong Xiao, Mitchell Ho, Zhongyu Zhu, Ira Pastan, Dimiter S Dimitrov. MAbs 2009
20
50

Suppression of FUT1 attenuates cell proliferation in the HER2-overexpressing cancer cell line NCI-N87.
Sadayuki Kawai, Shunsuke Kato, Hiroo Imai, Yoshinari Okada, Chikashi Ishioka. Oncol Rep 2013
23
50

Redirection of CD4+ and CD8+ T lymphocytes via an anti-CD3 × anti-CD19 bi-specific antibody combined with cytosine arabinoside and the efficient lysis of patient-derived B-ALL cells.
Dongmei Fan, Wei Li, Yuqi Yang, Xiaolong Zhang, Qing Zhang, Yan Yan, Ming Yang, Jianxiang Wang, Dongsheng Xiong. J Hematol Oncol 2015
21
50

Turning up the heat on non-immunoreactive tumours: opportunities for clinical development.
María Ochoa de Olza, Blanca Navarro Rodrigo, Stefan Zimmermann, George Coukos. Lancet Oncol 2020
29
50

Development of a Tetravalent Anti-GPA33/Anti-CD3 Bispecific Antibody for Colorectal Cancers.
Zhihao Wu, Hong-Fen Guo, Hong Xu, Nai-Kong V Cheung. Mol Cancer Ther 2018
17
50

Effector-attenuating Substitutions That Maintain Antibody Stability and Reduce Toxicity in Mice.
Megan Lo, Hok Seon Kim, Raymond K Tong, Travis W Bainbridge, Jean-Michel Vernes, Yin Zhang, Yuwen Linda Lin, Shan Chung, Mark S Dennis, Y Joy Yu Zuchero,[...]. J Biol Chem 2017
85
50

Study on the expression and clinical significances of lewis y antigen and integrin αv, β3 in epithelial ovarian tumors.
Yifei Wang, Juanjuan Liu, Bei Lin, Changzhi Wang, Quanrong Li, Shuice Liu, Limei Yan, Shulan Zhang, Masao Iwamori. Int J Mol Sci 2011
23
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.